Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.19B |
| 2 |
Microsoft
MSFT
|
+$1.07B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.06B |
| 4 |
Tesla
TSLA
|
+$1.01B |
| 5 |
Meta Platforms (Facebook)
META
|
+$691M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$689M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$525M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$450M |
| 4 |
KSU
Kansas City Southern
KSU
|
+$305M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.37% |
| 2 | Financials | 9.02% |
| 3 | Communication Services | 7.25% |
| 4 | Consumer Discretionary | 6.95% |
| 5 | Healthcare | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NPTN
3576
DELISTED
NEOPHOTONICS CORP
NPTN
| $208K | ﹤0.01% |
23,800
+754
| +3% | +$6.87K |
|
3577
Hurco Companies Inc
HURC
$135M
| $207K | ﹤0.01% |
6,429
+40
| +0.6% | +$1.33K |
|
3578
Silvercrest Asset Management
SAMG
$78.8M
| $207K | ﹤0.01% |
13,229
-2,826
| -18% | -$44.5K |
|
3579
PUT
Teva Pharmaceuticals
TEVA
$40.6B
| $206K | ﹤0.01% |
21,200
| – | – |
|
|
AERI
3580
CALL
DELISTED
Aerie Pharmaceuticals
AERI
| $206K | ﹤0.01% |
+18,100
| New | +$265K |
|
3581
PUT
HP
HPQ
$24.9B
| $205K | ﹤0.01% |
7,500
| – | – |
|
3582
Standard BioTools
LAB
$344M
| $205K | ﹤0.01% |
31,136
+21,535
| +224% | +$142K |
|
3583
Tidewater
TDW
$3.71B
| $205K | ﹤0.01% |
17,043
+11,360
| +200% | +$129K |
|
3584
Genesis Energy
GEL
$1.86B
| $204K | ﹤0.01% |
20,508
-2,525
| -11% | -$23.2K |
|
|
FRGI
3585
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $204K | ﹤0.01% |
18,580
+2,547
| +16% | +$32K |
|
|
SPNE
3586
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $204K | ﹤0.01% |
12,976
+12,973
| +432,433% | +$222K |
|
3587
CB Financial Services
CBFV
$191M
| $203K | ﹤0.01% |
8,675
-755
| -8% | -$17.4K |
|
3588
Aemetis
AMTX
$106M
| $202K | ﹤0.01% |
11,050
-6,791
| -38% | -$75.1K |
|
|
CALB
3589
DELISTED
California BanCorp Common Stock
CALB
| $202K | ﹤0.01% |
11,517
-1,572
| -12% | -$27.7K |
|
3590
FRP Holdings
FRPH
$433M
| $201K | ﹤0.01% |
7,202
+3,840
| +114% | +$110K |
|
3591
Hovnanian Enterprises
HOV
$748M
| $201K | ﹤0.01% |
2,093
+1,445
| +223% | +$144K |
|
3592
Rocky Brands
RCKY
$359M
| $201K | ﹤0.01% |
4,204
+3,313
| +372% | +$165K |
|
|
STR
3593
DELISTED
Sitio Royalties
STR
| $201K | ﹤0.01% |
10,669
+2,578
| +32% | +$48.1K |
|
|
BCEL
3594
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $201K | ﹤0.01% |
32,255
+20,272
| +169% | +$135K |
|
|
OBSV
3595
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $201K | ﹤0.01% |
64,885
-29,088
| -31% | -$82.3K |
|
3596
Angi Inc
ANGI
$222M
| $200K | ﹤0.01% |
1,622
-448
| -22% | -$51.5K |
|
3597
Expro Ltd
XPRO
$1.75B
| $200K | ﹤0.01% |
11,314
+6,602
| +140% | +$112K |
|
|
SYRS
3598
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $200K | ﹤0.01% |
4,486
-1,390
| -24% | -$67.9K |
|
|
STEL
3599
DELISTED
Stellar Bancorp
STEL
| $199K | ﹤0.01% |
7,521
+5,192
| +223% | +$138K |
|
3600
UroGen Pharma
URGN
$1.9B
| $198K | ﹤0.01% |
11,760
+5,060
| +76% | +$80.2K |
|
Similar funds
Barclays's Q3 2021 Portfolio in Review
As of Q3 2021, Barclays held 5,157 positions worth $222B, up 5% from $212B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $12.8B of net new capital in Q3 2021, opening 259 new positions and adding to 2,650 existing holdings. Its largest new stake was Invesco Zacks Mid-Cap ETF: 700,000 shares worth $62.9M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was State Street Technology Select Sector SPDR ETF, an estimated $689M trimmed.
- Barclays's largest Q3 2021 buy was Invesco Zacks Mid-Cap ETF: 700,000 shares worth $62.9M.
- Barclays added most to Amazon in Q3 2021, an estimated $1.19B increase.
- Barclays's biggest Q3 2021 reduction was State Street Technology Select Sector SPDR ETF, cutting an estimated $689M.
- Barclays fully exited GE Aerospace in Q3 2021, selling an estimated $248M.
- Barclays's ten largest holdings make up 31% of its $222B portfolio in Q3 2021.
- Barclays opened 259 new positions and closed 365 in Q3 2021.
- Barclays's portfolio value rose 5% quarter-over-quarter to $222B.
Based on Barclays's 13F filing for Q3 2021, filed 9 Nov 2021.